<DOC>
	<DOCNO>NCT01643135</DOCNO>
	<brief_summary>Tranexamic acid benn widely use reduce perioperative bleeding several operation cardiac surgery , liver transplant joint arthroplasty good result . Few study laminectomy conflict result vary dos . The objective compare perioperative bleeding major laminectomy patient receive double dos tranexamic acid ( 15 mg/kg 15 mg/kg ) receive pacebo ( 0.9 % NaCl ) .</brief_summary>
	<brief_title>Reduction Bleeding Laminectomy With Double Doses Tranexamic Acid</brief_title>
	<detailed_description>78 patient undergoing major laminectomy ( instrumentation equal 3 level laminectomy ) enrol . We exclude patient age 65 , anemia , allergy tranexamic acid , history deep vein thormbosis ( DVT ) , ischemic heart disease ( IHD ) , pulmonary embolism ( PE ) , stroke , liver disease , chronic kidney disease creatinine &gt; 2.0 mg/dl , coagulopathy . After randomization , induction 3 hour first dose , patient receive study drug placebo intravenously . The standard anesthesia monitoring tha patient . Perioperative mild hypotensive technique use mean arterial pressure 60 mmHg nearly end , blood pressure back normal bleeding check . Hematocrit monitor begin every two hour . Blood give hematocrit 30 % . The perioperative fluid manage anesthesiologist know patient ' group . The next morning , hematocrit blood creatinine check hematocrit lower 30 % , blood give . Perioperative blood loss , total fluid blood transfusion within 24 hour record . If suspect symptom sign DVT , angina , CHF , PE , strokes complication , necessory investigation do definite dignosis appropriate treatment start immediately .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<mesh_term>Tranylcypromine</mesh_term>
	<criteria>laminectomy instrumentation equal 3 level laminectomy age 1865 year ASA 13 elective operation allergy tranexamic acid anemia ( Hb &lt; 12 g/dl female Hb &lt; 13 g/dl male ) history CVT , IHD , PE , stroke liver disease chronic kidney disease creatinie &gt; 2.0 mg/dl receive anticoagulant coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>tranexamic acid</keyword>
	<keyword>bleeding</keyword>
	<keyword>blood transfusion</keyword>
	<keyword>spine surgery</keyword>
</DOC>